A Neuroscientist’s Journey Through Madness

After I was diagnosed with brain cancer and started to lose my mental health, the importance of my job came into clear focus.

Written byBarbara Lipska and Elaine McArdle
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Houghton Mifflin Harcourt, April 2018For more than 30 years as a neuroscientist, I (B.L.) have studied mental illness, in particular schizophrenia, a devastating disease that often makes it difficult for patients to distinguish between what is real and what is not. So it was with some irony that, three years ago, I myself ended up losing my mind, losing touch with what was happening around me. In the long run, I have come to see that terrifying journey, which I detail in my book, The Neuroscientist Who Lost Her Mind, as a gift, both personally and professionally.

In January 2015, two years after I became director of the Human Brain Collection Core at the National Institute of Mental Health (NIMH), I was diagnosed with brain metastatic melanoma and given four to seven months to live. But as an athlete and a breast cancer survivor, I had no intention of giving up easily. After brain surgery and radiation, I entered a clinical immunotherapy trial for patients with melanoma brain tumors at Georgetown University’s Lombardi Comprehensive Cancer Center.

Throughout the trial, I continued to work full-time at my office in Bethesda, Maryland, putting in long days overseeing my large staff, reviewing scientific articles, and managing the surging demand from researchers across the country to use our brain tissue samples. But unbeknownst to me or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

April 2018

Neuron Nets

Wrapped up in memory, addiction, and more

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies